Liberty Capital Corporation - Series C GCI Group Common Stock (NQ:GLIBK)
Price and Volume
Detailed Quote| Volume | 771,966 |
| Open | 22.18 |
| Bid (Size) | 19.00 (400) |
| Ask (Size) | 23.20 (100) |
| Prev. Close | 22.49 |
| Today's Range | 22.03 - 22.97 |
| 52wk Range | 19.30 - 41.17 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Earnings Scheduled For November 5, 2025 ↗
November 05, 2025
GCI Liberty Announces Completion of Rights Offering
December 23, 2025
Which stocks are moving before the opening bell on Monday? ↗
December 22, 2025
GCI Liberty Announces Terms for Previously Announced Rights Offering
November 24, 2025
GCI Liberty Reports Third Quarter 2025 Financial Results
November 05, 2025
Frequently Asked Questions
Is Liberty Capital Corporation - Series C GCI Group Common Stock publicly traded?
Yes, Liberty Capital Corporation - Series C GCI Group Common Stock is publicly traded.
What exchange does Liberty Capital Corporation - Series C GCI Group Common Stock trade on?
Liberty Capital Corporation - Series C GCI Group Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Liberty Capital Corporation - Series C GCI Group Common Stock?
The ticker symbol for Liberty Capital Corporation - Series C GCI Group Common Stock is GLIBK on the Nasdaq Stock Market
What is the current price of Liberty Capital Corporation - Series C GCI Group Common Stock?
The current price of Liberty Capital Corporation - Series C GCI Group Common Stock is 22.73
When was Liberty Capital Corporation - Series C GCI Group Common Stock last traded?
The last trade of Liberty Capital Corporation - Series C GCI Group Common Stock was at 07/08/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube